Results 71 to 80 of about 23,074,058 (199)

Pharmacovigilance evaluation of somatrogon-associated adverse events in real-world databases

open access: yesEndocrine Connections
Background: Somatrogon, a long-acting recombinant human growth hormone, is used in children with growth hormone deficiency. While clinical trials have shown its safety, real-world post-marketing data are limited, and uncommon or delayed adverse events ...
Mengyuan Cai   +5 more
doaj   +1 more source

Kinetic analysis of the dimerization and disproportionation of aqueous glyoxal

open access: yes, 2018
The benzilic acid-type rearrangement of glyoxal to glycolic acid was followed in 0.25 to 75mM NaOH and from 5 to 80(DEGREES)C by spectrophotometric analysis of residual glyoxal. At essentially constant alkalinity (15 to 400(mu)M glyoxal), a first-order dependence on total glyoxal was found.
openaire   +3 more sources

Disproportionality analysis of infection associated with antidiabetic drug use patterns

open access: yesScientific Reports
While various antidiabetic drug classes are associated with differing infection risks, comprehensive evidence on infection risk across multidrug regimens remains limited. Therefore, this study aims to investigate the pharmacovigilance signal between antidiabetic drug use and infection risk, considering the number and patterns of drug use.
Kim, Tae Hyeon   +13 more
openaire   +3 more sources

Disproportionality analysis of progestogens and estrogens demonstrates increased meningioma risk

open access: yesJournal of Clinical Neuroscience
This study aims to clarify the relationship between the use of various progestogens and estrogens and the risk of developing meningiomas, given the widespread prescription of hormonal contraceptives and their potential implications in tumour proliferation.Data from the FDA Adverse Event Reporting System (FAERS) was analyzed using disproportionality ...
Connor, Frey, Mahyar, Etminan
openaire   +2 more sources

Federal Policy on Disproportionality in Special Education

open access: yes, 2011
Monitoring requirements in the 1997 amendments to and 2004 reauthorization of the Individuals with Disabilities Education Act (IDEA) acknowledged the existence and extent of racial/ethnic disproportionality in special education, especially when, in 2004,
Choong-Geun Chung   +4 more
core   +1 more source

Risk Factors for Drug-Induced Acute Generalized Exanthematous Pustulosis(AGEP) from 2004 to 2024: A Real-World Study Based on the FAERS

open access: yesClinical, Cosmetic and Investigational Dermatology
Huafa Que,1,2 Xianglong Zheng,1,3 Xiaojian Li,1 Wanchun Wang1,3 1Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang, 330004, People’s Republic of China; 2Department of Traditional Chinese Surgery, Longhua Hospital Shanghai ...
Que H, Zheng X, Li X, Wang W
doaj  

Adverse events associated with statin co-use in breast cancer patients: a disproportionality analysis based on the FDA Adverse Event Reporting System

open access: yesTherapeutic Advances in Drug Safety
Background: An increasing number of breast cancer patients are using statins concomitantly. However, there are relatively few safety studies on the association between statins and adverse events (AEs) during breast cancer treatment. Objective: This study
Yunnan Zhang   +5 more
doaj   +1 more source

Post-licensure safety surveillance of 9-valent human papillomavirus vaccine using the vaccine adverse event reporting system, 2014–2024

open access: yesFrontiers in Public Health
BackgroundOn December 10, 2014, the Food and Drug Administration (FDA) licensed the 9-valent human papillomavirus vaccine (9vHPV) for prevention of HPV-related cancers and genital warts.
Jie-Hai Chen   +4 more
doaj   +1 more source

Using Administrative Data to Monitor Racial/Ethnic Disparities and Disproportionality Within Child Welfare Agencies: Process and Preliminary Outcomes

open access: yes, 2017
Child welfare administrative data are increasingly used to identify racial/ethnic disproportionality and disparities at various levels of aggregation. However, child welfare agencies typically face challenges in harnessing administrative data to examine ...
Michelle Johnson-Motoyama (12341431)   +7 more
core   +1 more source

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)

open access: yesScientific Reports
Sacubitril/valsartan, a first-in-class angiotensin receptor neprilysin inhibitor, is widely used to treat heart failure. Despite its efficacy, sacubitril/valsartan inevitably causes adverse events such as hypotension, renal dysfunction, hyperkalemia, and
Ning Wang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy